Sort by: Helpfulness | Most Recent
1 patient evaluation for Adalimumab taken for the purpose of 'Crohn's Disease' with a side effects rating of None
|Date||Dosage||Perceived effectiveness||Side Effects||Adherence||Burden|
|Apr 22, 2011||20 mg/0.4 mL Every Other Week||?Can't tell||None||Always||A little|
3 additional evaluations for Adalimumab are not currently shared publicly.